Wayspring is a healthcare startup founded in 2012 in the United States. The company's mission is reflected in its slogan, "A new way to wellness for people living with substance use disorder." Wayspring focuses on providing value-based healthcare to individuals with complex needs, particularly those living with substance use disorder. The organization offers a comprehensive and longitudinal model that encompasses medical, behavioral health, and social support services, as well as targeted member outreach, strategic provider partnerships, and community-based peer support. This approach has led to increased adherence to evidence-based medicine, decreased healthcare waste, and improved health outcomes. In its latest funding round on 21 May 2024, Wayspring secured a significant investment of $45.00M from a group of prominent investors, including .406 Ventures, CVS Health, HLM Venture Partners, and Valtruis. Wayspring's innovative approach to addressing the needs of individuals with substance use disorder, coupled with its strong investor backing, positions the company as a compelling player in the healthcare industry. With its focus on value-based care and demonstrated impact on healthcare outcomes, Wayspring presents a promising opportunity for venture capital investors looking to support disruptive solutions in the healthcare sector.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Series D | $45.00M | 4 | 21 May 2024 | |
Series D | $75.00M | 8 | The Blue Venture Fund, Centene +1 | 28 Sep 2021 |
Series C | $15.00M | 4 | The Blue Venture Fund | 27 Feb 2020 |
Series B | $16.50M | 4 | The Blue Venture Fund | 12 Oct 2016 |
Series A | $8.00M | 3 | The Blue Venture Fund | 14 Jul 2015 |
No recent news or press coverage available for Wayspring.